155 related articles for article (PubMed ID: 23748596)
1. Economic impacts of environmentally attributable childhood health outcomes in the European Union.
Bartlett ES; Trasande L
Eur J Public Health; 2014 Feb; 24(1):21-6. PubMed ID: 23748596
[TBL] [Abstract][Full Text] [Related]
2. Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities.
Landrigan PJ; Schechter CB; Lipton JM; Fahs MC; Schwartz J
Environ Health Perspect; 2002 Jul; 110(7):721-8. PubMed ID: 12117650
[TBL] [Abstract][Full Text] [Related]
3. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
[TBL] [Abstract][Full Text] [Related]
4. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union.
Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):1245-55. PubMed ID: 25742516
[TBL] [Abstract][Full Text] [Related]
5. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
Bellanger M; Demeneix B; Grandjean P; Zoeller RT; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1256-66. PubMed ID: 25742515
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of cancer across the European Union: a population-based cost analysis.
Luengo-Fernandez R; Leal J; Gray A; Sullivan R
Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
[TBL] [Abstract][Full Text] [Related]
7. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
Legler J; Fletcher T; Govarts E; Porta M; Blumberg B; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1278-88. PubMed ID: 25742518
[TBL] [Abstract][Full Text] [Related]
8. Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008.
Trasande L; Liu Y
Health Aff (Millwood); 2011 May; 30(5):863-70. PubMed ID: 21543421
[TBL] [Abstract][Full Text] [Related]
9. Toward an economic analysis of the environmental burden of disease among Canadian children.
Bérubé A
J Toxicol Environ Health B Crit Rev; 2007; 10(1-2):131-42. PubMed ID: 18074307
[TBL] [Abstract][Full Text] [Related]
10. Economic Burden of Bladder Cancer Across the European Union.
Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
[TBL] [Abstract][Full Text] [Related]
11. Poor environment creates wealth of problems.
McGovern V
Environ Health Perspect; 2002 Jun; 110(6):A292. PubMed ID: 12087982
[No Abstract] [Full Text] [Related]
12. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.
Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Hunt PM; Rudel R; Sathyanarayana S; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
Andrology; 2016 Jul; 4(4):565-72. PubMed ID: 27003928
[TBL] [Abstract][Full Text] [Related]
13. Female Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine Disrupting Chemicals in the European Union.
Hunt PA; Sathyanarayana S; Fowler PA; Trasande L
J Clin Endocrinol Metab; 2016 Apr; 101(4):1562-70. PubMed ID: 27003299
[TBL] [Abstract][Full Text] [Related]
14. Calculation of the disease burden associated with environmental chemical exposures: application of toxicological information in health economic estimation.
Grandjean P; Bellanger M
Environ Health; 2017 Dec; 16(1):123. PubMed ID: 29202828
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of cardiovascular diseases in the enlarged European Union.
Leal J; Luengo-Fernández R; Gray A; Petersen S; Rayner M
Eur Heart J; 2006 Jul; 27(13):1610-9. PubMed ID: 16495286
[TBL] [Abstract][Full Text] [Related]
16. Childhood lead exposure in France: benefit estimation and partial cost-benefit analysis of lead hazard control.
Pichery C; Bellanger M; Zmirou-Navier D; Glorennec P; Hartemann P; Grandjean P
Environ Health; 2011 May; 10():44. PubMed ID: 21599937
[TBL] [Abstract][Full Text] [Related]
17. Update on the clinical management of childhood lead poisoning.
Woolf AD; Goldman R; Bellinger DC
Pediatr Clin North Am; 2007 Apr; 54(2):271-94, viii. PubMed ID: 17448360
[TBL] [Abstract][Full Text] [Related]
18. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
19. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis.
Attina TM; Hauser R; Sathyanarayana S; Hunt PA; Bourguignon JP; Myers JP; DiGangi J; Zoeller RT; Trasande L
Lancet Diabetes Endocrinol; 2016 Dec; 4(12):996-1003. PubMed ID: 27765541
[TBL] [Abstract][Full Text] [Related]
20. Societal costs of exposure to toxic substances: economic and health costs of four case studies that are candidates for environmental causation.
Muir T; Zegarac M
Environ Health Perspect; 2001 Dec; 109 Suppl 6(Suppl 6):885-903. PubMed ID: 11744507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
